During the past decade, Q-Pharm Pty Ltd conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 1 clinical trials were completed, i.e. on average, 7.1% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 1 clinical trials were completed. i.e. 9.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Q-Pharm Pty Ltd" #1 sponsor was "Acrux DDS Pty Ltd" with 2 trials, followed by "Advaccine (Suzhou) Biopharmaceuticals Co., Ltd." with 1 trials sponsored, "Allergan" with 1 trials sponsored, "Angitia Biopharmaceuticals" with 1 trials sponsored and "Attralus, Inc." with 1 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Q-Pharm Pty Ltd" #1 collaborator was "Novotech (Australia) Pty Limited" with 3 trials as a collaborator, "Angitia Australia Pty Ltd" with 1 trials as a collaborator, "Hangzhou Sciwind Biosciences Co., Ltd." with 1 trials as a collaborator, "INCResearch Australia Pty Limited" with 1 trials as a collaborator and "MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Q-Pharm Pty Ltd" are "Celiac Disease" (2 trials), "Amyloidosis; Systemic" (1 trials), "Anaphylactic Reaction" (1 trials), "Asthma" (1 trials) and "Bacterial Vaginosis" (1 trials). Many other conditions were trialed in "Q-Pharm Pty Ltd" in a lesser frequency.

Most popular intervention types in "Q-Pharm Pty Ltd" are "Drug" (13 trials), "Biological" (6 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Testosterone MD-Lotion" (2 trials), "2x Base Dose EBOV GP Vaccine" (1 trials), "30 micrograms Nexvax2" (1 trials) and "4x Base Dose EBOV GP Vaccine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Q-Pharm Pty Ltd" are 15 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Q-Pharm Pty Ltd". 2 are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Q-Pharm Pty Ltd, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Q-Pharm Pty Ltd, 18 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".